Literature DB >> 34191143

Cardiac PET/MRI-an update.

C Rischpler1, S G Nekolla2,3, G Heusch4, L Umutlu5, T Rassaf6, P Heusch7, K Herrmann8, F Nensa5.   

Abstract

It is now about 8 years since the first whole-body integrated PET/MRI has been installed. First, reports on technical characteristics and system performance were published. Early after, reports on the first use of PET/MRI in oncological patients were released. Interestingly, the first article on the application in cardiology was a review article, which was published before the first original article was put out. Since then, researchers have gained a lot experience with the PET/MRI in various cardiovascular diseases and an increasing number on auspicious indications is appearing. In this review article, we give an overview on technical updates within these last years with potential impact on cardiac imaging and summarize those scenarios where PET/MRI plays a pivotal role in cardiovascular medicine.

Entities:  

Keywords:  Cardiovascular; Clinical applications; PET/MRI

Year:  2019        PMID: 34191143     DOI: 10.1186/s41824-018-0050-2

Source DB:  PubMed          Journal:  Eur J Hybrid Imaging        ISSN: 2510-3636


  66 in total

1.  Field of view extension and truncation correction for MR-based human attenuation correction in simultaneous MR/PET imaging.

Authors:  Jan O Blumhagen; Harald Braun; Ralf Ladebeck; Matthias Fenchel; David Faul; Klaus Scheffler; Harald H Quick
Journal:  Med Phys       Date:  2014-02       Impact factor: 4.071

2.  HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis.

Authors:  David H Birnie; William H Sauer; Frank Bogun; Joshua M Cooper; Daniel A Culver; Claire S Duvernoy; Marc A Judson; Jordana Kron; Davendra Mehta; Jens Cosedis Nielsen; Amit R Patel; Tohru Ohe; Pekka Raatikainen; Kyoko Soejima
Journal:  Heart Rhythm       Date:  2014-05-09       Impact factor: 6.343

3.  Performance measurements of the Siemens mMR integrated whole-body PET/MR scanner.

Authors:  Gaspar Delso; Sebastian Fürst; Björn Jakoby; Ralf Ladebeck; Carl Ganter; Stephan G Nekolla; Markus Schwaiger; Sibylle I Ziegler
Journal:  J Nucl Med       Date:  2011-11-11       Impact factor: 10.057

4.  Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis.

Authors:  Kevin C Allman; Leslee J Shaw; Rory Hachamovitch; James E Udelson
Journal:  J Am Coll Cardiol       Date:  2002-04-03       Impact factor: 24.094

5.  Investigating the state-of-the-art in whole-body MR-based attenuation correction: an intra-individual, inter-system, inventory study on three clinical PET/MR systems.

Authors:  Thomas Beyer; Martin L Lassen; Ronald Boellaard; Gaspar Delso; Maqsood Yaqub; Bernhard Sattler; Harald H Quick
Journal:  MAGMA       Date:  2016-01-06       Impact factor: 2.310

6.  Delay in revascularization is associated with increased mortality rate in patients with severe left ventricular dysfunction and viable myocardium on fluorine 18-fluorodeoxyglucose positron emission tomography imaging.

Authors:  R S Beanlands; P J Hendry; R G Masters; R A deKemp; K Woodend; T D Ruddy
Journal:  Circulation       Date:  1998-11-10       Impact factor: 29.690

7.  Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction.

Authors:  M F Di Carli; M Davidson; R Little; S Khanna; F V Mody; R C Brunken; J Czernin; S Rokhsar; L W Stevenson; H Laks
Journal:  Am J Cardiol       Date:  1994-03-15       Impact factor: 2.778

8.  Phase II safety and clinical comparison with single-photon emission computed tomography myocardial perfusion imaging for detection of coronary artery disease: flurpiridaz F 18 positron emission tomography.

Authors:  Daniel S Berman; Jamshid Maddahi; B K Tamarappoo; Johannes Czernin; Raymond Taillefer; James E Udelson; C Michael Gibson; Marybeth Devine; Joel Lazewatsky; Gajanan Bhat; Dana Washburn
Journal:  J Am Coll Cardiol       Date:  2012-12-19       Impact factor: 24.094

9.  Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis.

Authors:  Ron Blankstein; Michael Osborne; Masanao Naya; Alfonso Waller; Chun K Kim; Venkatesh L Murthy; Pedram Kazemian; Raymond Y Kwong; Michifumi Tokuda; Hicham Skali; Robert Padera; Jon Hainer; William G Stevenson; Sharmila Dorbala; Marcelo F Di Carli
Journal:  J Am Coll Cardiol       Date:  2013-10-16       Impact factor: 24.094

Review 10.  Molecular imaging of cardiac remodelling after myocardial infarction.

Authors:  Daniel Curley; Begoña Lavin Plaza; Ajay M Shah; René M Botnar
Journal:  Basic Res Cardiol       Date:  2018-01-17       Impact factor: 17.165

View more
  2 in total

1.  Regional analysis of inflammation and contractile function in reperfused acute myocardial infarction by in vivo 19F cardiovascular magnetic resonance in pigs.

Authors:  Florian Bönner; M Gastl; F Nienhaus; M Rothe; A Jahn; S Pfeiler; U Gross; H-P Schultheiss; B Ibanez; S Kozerke; J Szendroedi; M Roden; R Westenfeld; J Schrader; U Flögel; G Heusch; M Kelm
Journal:  Basic Res Cardiol       Date:  2022-04-07       Impact factor: 12.416

Review 2.  Integrated cardiovascular assessment of atherosclerosis using PET/MRI.

Authors:  Nicholas R Evans; Jason M Tarkin; Elizabeth Pv Le; Rouchelle S Sriranjan; Andrej Corovic; Elizabeth A Warburton; James Hf Rudd
Journal:  Br J Radiol       Date:  2020-04-03       Impact factor: 3.039

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.